Viewing Study NCT04227769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-02-09 @ 11:21 PM
Study NCT ID: NCT04227769
Status: TERMINATED
Last Update Posted: 2025-01-29
First Post: 2020-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes
Sponsor: University Hospital, Basel, Switzerland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus Type 2 in Obese View
None Inflammation View
None Metabolic Disease View
None Glucose Metabolism Disorders (Including Diabetes Mellitus) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anakinra View
None cephalic phase of insulin secretion View